For presentation materials, click here.

Financial institutions in Europe and the US are considering a range of products to address their funding needs. It's a difficult task, as it's still not known which products will receive beneficial regulatory capital treatment. National regulators also have provided guidance on additional or so-called buffer capital, as well as contingent capital products, commonly referred to as CoCos.

European banks have recently issued contingent capital products and these issuances face an uncertain regulatory framework, and evolving market practice. This webcast will discuss these considerations and focus on:

• Basel III guidance and status of implementation
• Bail-in capital, including national guidance
• Contingent capital products and structures
• Market experience
• Tax, ratings, corporate governance and other considerations relating to contingent capital
• Investor perspective

WestLegalEdcenter will offer CLE credit.